Previous Close | 41.94 |
Open | 41.99 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 41.51 - 42.22 |
52 Week Range | 35.62 - 53.00 |
Volume | |
Avg. Volume | 207,908 |
Market Cap | 55.266B |
Beta (5Y Monthly) | 0.60 |
PE Ratio (TTM) | 47.64 |
EPS (TTM) | 0.88 |
Earnings Date | Jul 25, 2024 |
Forward Dividend & Yield | 0.25 (0.59%) |
Ex-Dividend Date | May 23, 2024 |
1y Target Est | 44.15 |
NEW YORK, May 14, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an expansion of its relationship with Worldwide Clinical Trials ("Worldwide"), a full-service global contract research organization (CRO). The agreement will facilitate data-driven decision-making across Worldwide’s entire clinical operations with the implementation of Medidata AI and enable Worldwide to support customers by reducing trial ti
Press ReleaseVELIZY-VILLACOUBLAY, France — May 14, 2024 JLR and Dassault Systèmes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs Worldwide Five-year partnership marks the next phase of their long-standing collaboration to drive the automaker’s transformation for a good and responsible businessMore than 18,000 users globally will utilize virtual twins to increase the efficiency of vehicle engineering and digital manufacturing, save time, and reduce waste and cost
VELIZY-VILLACOUBLAY, France, May 14, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that it has extended its long-term strategic partnership with JLR for five years, heralding a new era of digital transformation at the automaker that will drive improved efficiency, collaborative innovation and sustainability throughout the enterprise.